Beijing Strong Biotechnologies, Inc. (300406.SZ) received a total of 4.34 million shares added by its shareholder China National Pharmaceutical Group Corporation.

24/09/2024

GMT Eight

Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that the shareholder China Meheco Group Investment Limited (referred to as "China Pharmaceutical Investment") has completed more than half of its plans to increase its holdings. The main body of the increase will increase 4.34 million shares through centralized bidding trading, with a total amount of 62.2838 million yuan.

EMPEROR WATCH & J (00887) signed a letter of intent for property leasing with Shanghai Commercial Bank.

Shanghai Pharmaceuticals Holding (02607) subsidiary Xinyi Golden has become the licensee holder for oral solution of Ammonium Sulfate, a listed pharmaceutical product.

Contact: contact@gmteight.com

Beijing Strong Biotechnologies, Inc. (300406.SZ) received a total of 4.34 million shares added by its shareholder China National Pharmaceutical Group Corporation.

RECOMMEND

XUANWU CLOUD (02392) repurchased 8.351 million shares in the first half of the year under the restricted stock award plan.

Million Stars (08093) announces profit increase, with expected annual net profits attributable to shareholders of approximately HK$13 million to HK$18 million, turning around from a loss compared to the previous year.

On September 24, MNSO (09896) spent approximately 9.792 million Hong Kong dollars to repurchase 376,000 shares on the New York Stock Exchange.